Subject Matter Experts

Paul G Shekelle(VA Greater Los Angeles Healthcare System), Chantelle Garritty(Ottawa Hospital), James M Gaylor(Tufts Medical Center), Marika J Suttorp, Sydne J Newberry, Mei Chung(Tufts University), Ethan M. Balk(New York University), Jounghee Lee(Tufts Medical Center), Rebecca Skidmore, Helen Wu(RAND Corporation), Aneesa Motala(University of Southern California), Mohammed Ansari(University of Ottawa), Yee-Wei Lim(RAND Corporation), David Moher(University of Ottawa), Winifred W Yu(Tufts Medical Center)

Unknown

June 1, 2011

Cited by 10

Related Papers

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

|Data Archiving and Networked Services (DANS)|2002|11.7k

CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials

|BMJ|2010|9k

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

|Annals of Internal Medicine|2015|8.2k

National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

|Annals of Internal Medicine|2003|4.6k

Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement

|Journal of Clinical Epidemiology|2021|2.8k